Inhalation & Respiratory Drug Delivery 2021 • BioTech Pharma Summit

Description

The IRDD Stream is designed for senior industry experts that will showcase new trends in aerosol science and the future directions of inhalation drug delivery research. Further discussion focusses on the regulatory pathways for inhaled therapies and challenges of bringing respiratory products to market. The agenda also features key case studies on the latest trends in inhalation devices, from inhaled ins. to gene therapy.

A recent report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found America’s biopharmaceutical companies are developing about 130 new medicines for the millions of patients affected by respiratory diseases: chronic obstructive pulmonary disease (COPD), cystic fibrosis, pneumonia, and asthma. These medicines represent critical advancements in respiratory care and improving quality of life. In addition to the drugs, devices delivering those products are being designed to improve the quality of life for an aging population, children, and those who tend not to comply to dosing regimens because they don’t know how to use the device. The global respiratory care devices market is expected to exceed more than $24 billion by 2022,2 and could exceed $33 billion by 2023.

This stream will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled ins. to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis. The event highlights some of the innovators and innovations in the respiratory sector, addresses the importance of end users in the device development process, and presents recent advancements in improving patient adherence.

Key Practical Points

Novel technologies for pulmonary & nasal delivery
Modern respiratory medicines
Innovative development of inhalation devices
Digital health combination products
Analytical tools for inhaled medicines
Challenges of bringing inhalation and respiratory drug delivery products to market
Regulatory updates in the global respiratory market
The challenges of developing inhalation devices
Alternative therapeutic fields
Innovation in nebulised therapy
Triple inhaler therapy in COPD

Inhaled drugs through functional respiratory imaging (FRI) and artificial intelligence (AI)
Dry-powder inhalers (DPIs) and Metered-dose inhalers (MDIs)
New analytical insights into dry powder formulations for inhalation
Routes to controlling aerosol response
Characterizing aerosol dynamics
Model validation
Future directions in inhalation and respiratory drug delivery research
Regulatory pathways for inhaled therapies
Strategies for Managing the Impact of Brexit
Challenges of developing a generic inhaled product
Explore opportunities with smart and digital inhalers

Who should attend?

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from pharmaceutical/biotechnology industry / industries involved in:

Respiratory Drug Development
Generics & Respiratory
Inhalation Drug Delivery Technologies
Device Development and Engineering
Respiratory Pharmacology
Medical Devices & Injectors
Inhalation Device Development
Inhaled Formulation Science
Inhalation Product Development
Respiratory Regulations
Generics & Respiratory

Inhalation Process Development
Respiratory Medicine
Inhalation Drug Delivery
E-Health
Inhaled Dosage Forms
Outsourcing
Process Development
Respiratory Pharmacology
Device Engineering
Drug Delivery Innovation
Inhalation Devices

Metered Dose Inhaler Development
Medical Marketing
Respiratory R&D
Particle Characterisation
Business Development
New Delivery Technologies
Connective Health
Respiratory Regulations
Pulmonary Disease
Inhalation
Scientific Research

Exhibitors & Sponsors

Bronze Sponsor

Booth #E13

Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years’ industry experience, Catalent has proven expertise in bringing more customers’ products to market faster, enhancing product performance, and ensuring reliable clinical and commercial product supply.

Visit Website

Exhibitors & Sponsors

Booth #E6

Munit

MUNIT is a new and innovative consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics. In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership.

Visit Website

Booth #E15

Harro Höfliger

Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.
The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production.

Show less

Visit Website

Booth #E7

IGS B.V.

High Precision Moulds: From glasses and contact lenses to asthma inhalers, insulin pens and blood diagnostic devices. Our work can be found in products where extreme precision is vital. We believe that constantly pushing the envelope and delivering work of the highest possible quality is the key to making people all over the world healthier and happier. Medical Packaging: IGS produces moulds for caps, cases, closures, blisters and lids. Discover how our world-class engineers can make your production easier, faster and less expensive. Drug Delivery: IGS produces moulds for a wide variety of drug delivery devices, from syringes to metered dose inhalers, dose counters, dry powder inhalers and patch pump. Learn more about our smart design and engineering solutions. Diagnostics: In vitro diagnostics applications require high cavitation moulds and perfect component interchangeability. Find out how IGS can help you in the production of smart disposable consumables. Please visit us at Booth E7

Show less

Visit Website

Hovione

Hovione is an international company with over 60 years of experience as a Pharma Contract Development and Manufacturing Organization (CDMO) and is currently a fully integrated supplier offering services for drug substance, drug product intermediate and drug product.

With four FDA inspected sites in the USA, China, Ireland and Portugal and development laboratories in Lisbon, Portugal and New Jersey, USA, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds. For generic pharmaceutical customers the company offers niche API products.

In the inhalation area, Hovione is the only independent company offering a complete range of services.

Hovione - In it for life

Show less

Visit Website